Study of the Preventive Effects and Mechanisms of Yeast β-Glucan on Upper Respiratory Tract Infections

NANot yet recruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

July 25, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Upper Respiratory Tract Infections
Interventions
DIETARY_SUPPLEMENT

yeast β-glucan

Participants in the intervention group will take yeast β-glucan capsules daily. Each capsule contains 250 mg of yeast β-glucan, along with an appropriate amount of maltodextrin and silicon dioxide. All participants in the intervention group will take two capsules once daily, swallowed with warm water after meals.

DIETARY_SUPPLEMENT

placebo

Participants in the placebo group will take two placebo capsules once daily in the same manner. The placebo capsules are identical to the intervention capsules in form, taste, appearance, and packaging, but contain only maltodextrin and a small amount of silicon dioxide.

Trial Locations (1)

Unknown

School of Public Health, Lanzhou University, Lanzhou

All Listed Sponsors
lead

LanZhou University

OTHER